REGN846
R846-AD-1105
Phase 2 small_molecule terminated
Quick answer
REGN846 for Pruritus is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Pruritus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated